Sorrento Financial Statements From 2010 to 2024
| SRNE Stock | USD 0 0.0007 28.00% |
Check Sorrento Therape financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sorrento Therape's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sorrento financial statements analysis is a perfect complement when working with Sorrento Therape Valuation or Volatility modules.
Sorrento |
Sorrento Therape OTC Stock Return On Equity Analysis
Sorrento Therape's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sorrento Therape Return On Equity | -3.79 |
Most of Sorrento Therape's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sorrento Therape is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sorrento Therape has a Return On Equity of -3.7892. This is 84.19% lower than that of the Biotechnology sector and 89.61% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Sorrento Therape Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sorrento Therape's current stock value. Our valuation model uses many indicators to compare Sorrento Therape value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sorrento Therape competition to find correlations between indicators driving Sorrento Therape's intrinsic value. More Info.Sorrento Therape is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sorrento Therape's earnings, one of the primary drivers of an investment's value.About Sorrento Therape Financial Statements
Sorrento Therape stakeholders use historical fundamental indicators, such as Sorrento Therape's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sorrento Therape investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sorrento Therape's assets and liabilities are reflected in the revenues and expenses on Sorrento Therape's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sorrento Therape. Please read more on our technical analysis and fundamental analysis pages.
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. The company was founded in 2006 and is based in San Diego, California. Sorrento Therpt operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 799 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sorrento OTC Stock
Sorrento Therape financial ratios help investors to determine whether Sorrento OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sorrento with respect to the benefits of owning Sorrento Therape security.